A detailed history of 1832 Asset Management L.P. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, 1832 Asset Management L.P. holds 913,270 shares of TMO stock, worth $519 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares
913,270
Previous 1,494,702 38.9%
Holding current value
$519 Million
Previous $793 Million 33.1%
% of portfolio
1.03%
Previous 1.59%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$528.82 - $599.43 $307 Million - $349 Million
-581,432 Reduced 38.9%
913,270 $531 Million
Q4 2023

Feb 13, 2024

BUY
$431.41 - $532.94 $31.5 Million - $39 Million
73,089 Added 5.14%
1,494,702 $793 Million
Q3 2023

Nov 13, 2023

BUY
$498.29 - $574.41 $708 Million - $817 Million
1,421,613 New
1,421,613 $720 Million
Q2 2023

Aug 11, 2023

BUY
$508.46 - $591.13 $109,318 - $127,092
215 Added 0.02%
1,253,565 $654 Million
Q1 2023

May 12, 2023

BUY
$535.0 - $604.82 $14 Million - $15.9 Million
26,210 Added 2.14%
1,253,350 $722 Million
Q4 2022

Feb 14, 2023

BUY
$484.71 - $571.37 $91.7 Million - $108 Million
189,187 Added 18.23%
1,227,140 $676 Million
Q3 2022

Nov 14, 2022

SELL
$507.19 - $604.49 $2.37 Million - $2.83 Million
-4,675 Reduced 0.45%
1,037,953 $526 Million
Q2 2022

Aug 15, 2022

BUY
$500.9 - $612.21 $90.4 Million - $111 Million
180,533 Added 20.94%
1,042,628 $566 Million
Q1 2022

May 16, 2022

BUY
$524.0 - $644.92 $86.7 Million - $107 Million
165,450 Added 23.75%
862,095 $502 Million
Q4 2021

Feb 15, 2022

BUY
$569.0 - $667.24 $39.2 Million - $46 Million
68,925 Added 10.98%
696,645 $467 Million
Q3 2021

Nov 15, 2021

SELL
$509.53 - $609.78 $41.9 Million - $50.2 Million
-82,329 Reduced 11.59%
627,720 $366 Million
Q2 2021

Aug 16, 2021

SELL
$441.0 - $508.24 $13 Million - $15 Million
-29,496 Reduced 3.99%
710,049 $360 Million
Q1 2021

May 17, 2021

BUY
$439.85 - $518.83 $70.2 Million - $82.8 Million
159,576 Added 27.51%
739,545 $335 Million
Q4 2020

Feb 16, 2021

SELL
$435.06 - $527.66 $78.4 Million - $95.1 Million
-180,161 Reduced 23.7%
579,969 $268 Million
Q3 2020

Nov 16, 2020

BUY
$359.77 - $441.52 $66.3 Million - $81.4 Million
184,380 Added 32.02%
760,130 $332 Million
Q2 2020

Aug 14, 2020

BUY
$275.2 - $362.34 $80 Million - $105 Million
290,633 Added 101.93%
575,750 $203 Million
Q1 2020

May 26, 2020

BUY
$255.3 - $340.05 $3.92 Million - $5.22 Million
15,340 Added 5.69%
285,117 $81.7 Million
Q1 2020

May 14, 2020

SELL
$255.3 - $340.05 $2.84 Million - $3.78 Million
-11,125 Reduced 3.96%
269,777 $77.3 Million
Q4 2019

Feb 14, 2020

BUY
$271.93 - $328.04 $55.1 Million - $66.5 Million
202,603 Added 258.76%
280,902 $91.7 Million
Q3 2019

Nov 14, 2019

SELL
$268.46 - $305.43 $149 Million - $170 Million
-555,604 Reduced 87.65%
78,299 $22.3 Million
Q2 2019

Aug 14, 2019

SELL
$257.51 - $295.55 $42.3 Million - $48.5 Million
-164,140 Reduced 20.57%
633,903 $186 Million
Q1 2019

May 15, 2019

BUY
$212.17 - $273.72 $5.39 Million - $6.96 Million
25,413 Added 3.29%
798,043 $217 Million
Q4 2018

Feb 14, 2019

BUY
$208.47 - $251.98 $37.4 Million - $45.2 Million
179,210 Added 30.2%
772,630 $173 Million
Q3 2018

Nov 14, 2018

BUY
$205.57 - $244.32 $32 Million - $38 Million
155,620 Added 35.55%
593,420 $145 Million
Q2 2018

Aug 14, 2018

BUY
$203.14 - $219.53 $26.5 Million - $28.7 Million
130,534 Added 42.48%
437,800 $90.7 Million
Q1 2018

May 15, 2018

BUY
$192.98 - $224.11 $43.5 Million - $50.5 Million
225,203 Added 274.43%
307,266 $63.6 Million
Q4 2017

Feb 14, 2018

SELL
$182.03 - $200.37 $80.9 Million - $89.1 Million
-444,549 Reduced 84.42%
82,063 $15.5 Million
Q3 2017

Nov 14, 2017

BUY
$171.74 - $194.04 $90.4 Million - $102 Million
526,612
526,612 $96.6 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $223B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track 1832 Asset Management L.P. Portfolio

Follow 1832 Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on 1832 Asset Management L.P. with notifications on news.